The basics of Monoclonal Antibody Development and Antibody Production

 

Antibody Production Services

 Genosphere Biotechnologies offers complete polyclonal antibody production services packages, including peptide or protein antigen synthesis, choice of hosts immunization, antibody purification, and quality control analyses.

 Our polyclonal antibody production services are designed to meet a variety of experimental requirements. For example, depending of the planned experiments, antisera or purified antibodies can be provided. Multiple purification methods are available, including protein A and antigen affinity purification.  Purification of the antisera is used to enrich the antibody activities.

 Genosphere Biotechnologies has long experience in successful polyclonal antibody development and guarantees an ELISA titer above 1:100,000.  We offer multiple packages that can fit various customer needs. Our featured development packages can guarantee the delivery of fully-validated rabbit, guinea pig, rat, or mouse  polyclonal antibodies within 70 days.

 Our polyclonal antibody development services are based on years of process optimization and a strong reputation for reliable antibody production services. We have been a preferred partner to various institutions worldwide for antibody development and antibody production services for over 25 years.

 Antibody Production Services Highlights

•  Guaranteed ELISA titer >1:50,000. 

•  Proprietary peptide design tools and high-efficiency conjugation ensure a >95% success rate of peptide immunization.

•  Integrated antigen preparation:  from gene synthesis to protein antigen expression and purification

 Monoclonal Antibody Development

 Mouse monoclonal antibodies have broad applications as therapeutics, diagnostic tools, and research reagents. Genosphere Biotechnologies provides comprehensive mouse monoclonal antibody development services based on our well-established hybridoma platform. We provide complete support for all steps of mouse monoclonal antibody development, from antigen preparation to animal immunization, fusion and screening, subcloning, and antibody production, which allows the identification of clones with the desirable qualities.

We provide free consultation for target antigen design and expression, and our experienced project managers and scientists will support you directly throughout the process. 

 Since the Nobel-winning prize pioneer work in 1975 on hybridoma technique the monoclonal antibody development and manufacturing process has been refined.  In a nutshell, the generation of hybridomas involves immunising mice against a specific epitope on an antigen and obtaining the B-lymphocytes from the spleen of the animals. The B-lymphocytes are then fused with an immortal myeloma cell line lacking the hypoxanthine-guanine-phosphoribosyltransferase (HGPRT) gene. These hybridoma cells are further cultured in vitro in selective medium (i.e. hypoxanthine-aminopterin-thymidine +) where only the hybridomas -that is the fusion between the primary B-lymphocytes and myeloma cells- can survive as they have inherited immortality from the myeloma cells and selective-resistance from the primary B-lymphocytes.  The initial culture of hybridomas contains a pool of antibodies derived from many different primary B-lymphocyte clones, each secreting its own individual specific antibody into the culture medium hence, at this point, the antibodies are still polyclonals. Each individual clone is separated by dilution and the supernatant screened for the targeted specific antibody.  These cells are then characterized and cloned to allow production over time.

 

Comments

Post a Comment

Popular posts from this blog

Peptides with Fluorescent Labels

  Different fluorescent dyes can be attached to peptides in different locations to label them. For a wide variety of imaging and diagnostic applications, fluorescent tags or probes are perfect. Applications for fluorescent peptide synthesis include localization investigations, peptide-protein interactions, enzyme activity assays, in vivo biomedical imaging research, and the creation of new disease models. Fluorescence microscopy and other fluorescence visualization methods can be used to see fluorochrome-conjugated peptides. An indirect method of labeling is to use an amino acid that has been biotinylated. The acceptor and quencher components may be joined inside or outside. For longer sequences, the internal connection is advised. Studies on protein binding and localization, as well as in vivo biomedical imaging, typically make use of fluorescently tagged peptides. Fluorescence microscopy and other fluorescence visualization methods can be used to see fluorochrome-conjugated pe...
Read more

Our Custom Peptide Synthesis Services Market

  Rising research & development by biotechnology and pharmaceutical businesses are the primary factor growing the necessity for custom peptide synthesis services . The lack of time among the researcher and scientists to prepare their customized peptides may push the growth of the Custom Peptide Synthesis Services market. Also, increasing studies in academic & research organizations in the arena such as biochemistry & molecular biology is predictable to increase the demand for tailored peptides among students which will eventually upsurge the development of the custom Peptide Synthesis Services market. Also, the absence of funding from academic institutes in developing economies may help to hamper the growth of the market. Our Custom Peptide Synthesis Services Market Overview The custom peptide synthesis services market is predicted to show double growth over the forecast period owing to the rise in demand by the manufacturers for custom peptide synthesis services. B...
Read more

¿Cómo se Fabrican los Anticuerpos Para su uso?

  Es útil tener una comprensión general de cómo el sistema inmunitario producción de anticuerpos mientras se construye una producción de pruebas. Cuando el sistema inmunitario de un organismo entra en contacto por primera vez con una molécula extraña, generalmente una proteína, células especializadas como las células dendríticas y los macrófagos toman la molécula y comienzan a descomponerla para que puedan transmitir estos antígenos a los linfocitos de células B. Un proceso conocido como hipermutación somática permite que la célula B comience a codificar un nuevo anticuerpo después de que se haya producido la presentación del antígeno a los linfocitos de la célula B. Este anticuerpo tendrá un sitio de unión a antígeno distintivo en la región variable que puede unirse específicamente a un epítopo del antígeno. Cada linfocito de célula B produce un anticuerpo distinto en respuesta a un epítopo distinto. La célula B comienza a liberar anticuerpos en el torrente sanguíneo una vez qu...
Read more